Telehealth in clinical research: An ethical evaluation of teletrials
Telehealth is increasingly being integrated into clinical research to streamline trial processes and overcome access barriers. Teletrials, a decentralised clinical trial model, utilise telehealth to connect participants and research personnel at smaller research centres with staff at more experienced research institutions. This facilitates the operation of clinical trials in settings that may otherwise lack the resources required for participation. The Australian state of Queensland is constructing a state-wide palliative care teletrial network, connecting all adult health districts to a primary research site. This model aims to provide clinical trial access to all Queenslanders with advanced cancer. It represents one of the earliest attempts to provide clinical trial access to all patients in a select field within a jurisdiction. However, attempts to define the role and design of telehealth, including teletrials, in research, should be grounded in consideration of the potential benefits and harms. The four pillars of bioethics, beneficence, non-maleficence, autonomy and justice, offer a useful framework for grounding this discussion. Teletrials enhance access to therapies (beneficence) and decrease geographic inequity (justice) but may cause harm to individuals and communities (non-maleficence) and pose challenges in maintaining informed consent (autonomy). Resource diversion can lead to distributive injustice.
Authors
- Bernadette J. Richards (ORCID: https://orcid.org/0000-0001-6448-4954)
- Phillip D. Good (ORCID: https://orcid.org/0000-0002-8198-0375)
- ROBERT A. WAUGH (ORCID: https://orcid.org/0009-0002-9629-0585)
Institutions
- Mater Health Services (AU)
- The University of Queensland (AU)
- Mayne Pharma (Australia) (AU)
Publication Details
- Journal
- Journal of Telemedicine and Telecare
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1177/1357633x261503051
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00